Inhibition of interleukin-1 but not tumor necrosis factor suppresses neovascularization in rat models of corneal angiogenesis and adjuvant arthritis

被引:79
作者
Coxon, A [1 ]
Bolon, B [1 ]
Estrada, J [1 ]
Kaufman, S [1 ]
Scully, S [1 ]
Rattan, A [1 ]
Duryea, D [1 ]
Hu, YL [1 ]
Rex, K [1 ]
Pacheco, E [1 ]
Van, G [1 ]
Zack, D [1 ]
Feige, U [1 ]
机构
[1] Amgen Inc, Thousand Oaks, CA 91320 USA
来源
ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 10期
关键词
D O I
10.1002/art.10546
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To assess the capacities of the cytokine inhibitors interleukin-1 receptor antagonist (IL-1Ra; anakinra) and PEGylated soluble tumor necrosis factor receptor I (PEG sTNFR1; pegsunercept) to suppress neovascularization. Methods. A corneal angiogenesis assay was performed by implanting nylon discs impregnated with an angiogenic stimulator (basic fibroblast growth factor or vascular endothelial growth factor) into one cornea of female Sprague-Dawley rats. Animals were treated with IL-1Ra or PEG sTNFRI for 7 days, after which new vessels were quantified. In a parallel study, male Lewis rats with mycobacteria-induced adjuvant-induced arthritis were treated with IL-1Ra or PEG sTNFRI for 7 days beginning at disease onset, after which scores for inflammation and bone erosion as well as capillary counts were acquired from sections of arthritic hind paws. Results. Treatment with IL-1Ra yielded a dose-dependent reduction in growth factor-induced corneal angiogenesis, while PEG sTNFRI did not. IL-1Ra, but not PEG sTNFRI, significantly reduced the number of capillaries in arthritic paws, even though both anticytokines reduced inflammation and bone erosion to a similar degree. Conclusion. These data support a major role for IL-1, but not TNFalpha, in angiogenesis and suggest that an additional antiarthritic mechanism afforded by IL-1 inhibitors, but not anti-TNF agents, is the suppression of the angiogenic component of pannus.
引用
收藏
页码:2604 / 2612
页数:9
相关论文
共 53 条
[21]  
Jackson JR, 1997, J RHEUMATOL, V24, P1253
[22]   Anticytokine treatment of established type II collagen-induced arthritis in DBA/1 mice - A comparative study using anti-TNF alpha, anti-IL-1 alpha/beta, and IL-1Ra [J].
Joosten, LAB ;
Helsen, MMA ;
vandeLoo, FAJ ;
vandenBerg, WB .
ARTHRITIS AND RHEUMATISM, 1996, 39 (05) :797-809
[23]  
Kenyon BM, 1996, INVEST OPHTH VIS SCI, V37, P1625
[24]   SIMULTANEOUS BLOCK OF INTERLEUKIN-1 AND TUMOR-NECROSIS-FACTOR IS REQUIRED TO COMPLETELY PREVENT BONE LOSS IN THE EARLY POSTOVARIECTOMY PERIOD [J].
KIMBLE, RB ;
MATAYOSHI, AB ;
VANNICE, JL ;
KUNG, VT ;
WILLIAMS, C ;
PACIFICI, R .
ENDOCRINOLOGY, 1995, 136 (07) :3054-3061
[25]  
KOCH AE, 1994, J IMMUNOL, V152, P4149
[26]   Different roles of tumour necrosis factor α and interleukin 1 in murine streptococcal cell wall arthritis [J].
Kuiper, S ;
Joosten, LAB ;
Bendele, AM ;
Edwards, CK ;
Arntz, OJ ;
Helsen, MMA ;
van de Loo, FAJ ;
van den Berg, WB .
CYTOKINE, 1998, 10 (09) :690-702
[27]   MACROPHAGE-INDUCED ANGIOGENESIS IS MEDIATED BY TUMOR-NECROSIS-FACTOR-ALPHA [J].
LEIBOVICH, SJ ;
POLVERINI, PJ ;
SHEPARD, HM ;
WISEMAN, DM ;
SHIVELY, V ;
NUSEIR, N .
NATURE, 1987, 329 (6140) :630-632
[28]   Vascular endothelial growth factor expression and regulation of murine collagen-induced arthritis [J].
Lu, J ;
Kasama, T ;
Kobayashi, K ;
Yoda, Y ;
Shiozawa, F ;
Hanyuda, M ;
Negishi, M ;
Ide, H ;
Adachi, M .
JOURNAL OF IMMUNOLOGY, 2000, 164 (11) :5922-5927
[29]  
Maeno N, 1999, J RHEUMATOL, V26, P2244
[30]   Cyclo-oxygenase-2 enhances basic fibroblast growth factor-induced angiogenesis through induction of vascular endothelial growth factor in rat sponge implants [J].
Majima, M ;
Hayashi, I ;
Muramatsu, M ;
Katada, J ;
Yamashina, S ;
Katori, M .
BRITISH JOURNAL OF PHARMACOLOGY, 2000, 130 (03) :641-649